These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 9519833)

  • 1. Viral and cellular requirements for entry of herpes simplex virus type 1 into primary neuronal cells.
    Immergluck LC; Domowicz MS; Schwartz NB; Herold BC
    J Gen Virol; 1998 Mar; 79 ( Pt 3)():549-59. PubMed ID: 9519833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Herpes simplex virus glycoprotein B binds to cell surfaces independently of heparan sulfate and blocks virus entry.
    Bender FC; Whitbeck JC; Lou H; Cohen GH; Eisenberg RJ
    J Virol; 2005 Sep; 79(18):11588-97. PubMed ID: 16140736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in the role of glycoprotein C of HSV-1 and HSV-2 in viral binding may contribute to serotype differences in cell tropism.
    Gerber SI; Belval BJ; Herold BC
    Virology; 1995 Dec; 214(1):29-39. PubMed ID: 8525631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycoprotein C-independent binding of herpes simplex virus to cells requires cell surface heparan sulphate and glycoprotein B.
    Herold BC; Visalli RJ; Susmarski N; Brandt CR; Spear PG
    J Gen Virol; 1994 Jun; 75 ( Pt 6)():1211-22. PubMed ID: 8207388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neomycin inhibits glycoprotein C (gC)-dependent binding of herpes simplex virus type 1 to cells and also inhibits postbinding events in entry.
    Herold BC; Spear PG
    Virology; 1994 Aug; 203(1):166-71. PubMed ID: 8030274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycoprotein B plays a predominant role in mediating herpes simplex virus type 2 attachment and is required for entry and cell-to-cell spread.
    Cheshenko N; Herold BC
    J Gen Virol; 2002 Sep; 83(Pt 9):2247-2255. PubMed ID: 12185280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular and viral requirements for rapid endocytic entry of herpes simplex virus.
    Nicola AV; Straus SE
    J Virol; 2004 Jul; 78(14):7508-17. PubMed ID: 15220424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-function analysis of herpes simplex virus glycoprotein B with fusion-from-without activity.
    Roller DG; Dollery SJ; Doyle JL; Nicola AV
    Virology; 2008 Dec; 382(2):207-16. PubMed ID: 18950828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modified entry and syncytium formation by herpes simplex virus type 1 mutants selected for resistance to heparin inhibition.
    Pertel PE; Spear PG
    Virology; 1996 Dec; 226(1):22-33. PubMed ID: 8941319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetic analysis of glycoprotein C of herpes simplex virus types 1 and 2 binding to heparin, heparan sulfate, and complement component C3b.
    Rux AH; Lou H; Lambris JD; Friedman HM; Eisenberg RJ; Cohen GH
    Virology; 2002 Mar; 294(2):324-32. PubMed ID: 12009874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparin inhibition of insulin-like growth factor-binding protein-3 binding to human fibroblasts and rat glioma cells: role of heparan sulfate proteoglycans.
    Yang YW; Yanagishita M; Rechler MM
    Endocrinology; 1996 Oct; 137(10):4363-71. PubMed ID: 8828497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific targeted binding of herpes simplex virus type 1 to hepatocytes via the human hepatitis B virus preS1 peptide.
    Argnani R; Boccafogli L; Marconi PC; Manservigi R
    Gene Ther; 2004 Jul; 11(13):1087-98. PubMed ID: 15057264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Herpes simplex virus type 1-induced hemagglutination: glycoprotein C mediates virus binding to erythrocyte surface heparan sulfate.
    Trybala E; Svennerholm B; Bergström T; Olofsson S; Jeansson S; Goodman JL
    J Virol; 1993 Mar; 67(3):1278-85. PubMed ID: 8382294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of herpes simplex virus infection by lactoferrin is dependent on interference with the virus binding to glycosaminoglycans.
    Marchetti M; Trybala E; Superti F; Johansson M; Bergström T
    Virology; 2004 Jan; 318(1):405-13. PubMed ID: 14972565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonmuscle myosin heavy chain IIb mediates herpes simplex virus 1 entry.
    Arii J; Hirohata Y; Kato A; Kawaguchi Y
    J Virol; 2015 Feb; 89(3):1879-88. PubMed ID: 25428876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Herpes simplex virus entry is associated with tyrosine phosphorylation of cellular proteins.
    Qie L; Marcellino D; Herold BC
    Virology; 1999 Apr; 256(2):220-7. PubMed ID: 10191187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of structural features of heparin required for inhibition of herpes simplex virus type 1 binding.
    Herold BC; Gerber SI; Polonsky T; Belval BJ; Shaklee PN; Holme K
    Virology; 1995 Feb; 206(2):1108-16. PubMed ID: 7856085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Random mutagenesis of the gene encoding a viral ligand for multiple cell entry receptors to obtain viral mutants altered for receptor usage.
    Yoon M; Spear PG
    Proc Natl Acad Sci U S A; 2004 Dec; 101(49):17252-7. PubMed ID: 15557552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in the susceptibility of herpes simplex virus types 1 and 2 to modified heparin compounds suggest serotype differences in viral entry.
    Herold BC; Gerber SI; Belval BJ; Siston AM; Shulman N
    J Virol; 1996 Jun; 70(6):3461-9. PubMed ID: 8648678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell-specific kinetics and efficiency of herpes simplex virus type 1 entry are determined by two distinct phases of attachment.
    McClain DS; Fuller AO
    Virology; 1994 Feb; 198(2):690-702. PubMed ID: 8291250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.